热景生物：首次回购约20万股

Group 1 - The company, Hotgen Biotech (SH 688068), announced its first share repurchase on November 12, 2025, buying approximately 200,000 shares, which represents 0.2185% of its total share capital, with a total expenditure of about 30.01 million yuan [1] - The repurchased shares were acquired at a minimum price of 145.59 yuan per share and a maximum price of 152.18 yuan per share [1] - For the year 2024, the company's revenue composition is heavily weighted towards in vitro diagnostic products, which account for 98.85% of total revenue, while other businesses contribute only 1.15% [1] Group 2 - As of the report, Hotgen Biotech has a market capitalization of 15.8 billion yuan [1]